Alendronate is in a class of drugs called bisphosphonates used to prevent and treat certain types of bone loss (osteoporosis) in adults.
This report contains market size and forecasts of Alendronate in global, including the following market information:
Global Alendronate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alendronate Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Alendronate companies in 2021 (%)
The global Alendronate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alendronate include Merck, Teva, Mylan, Apotex, Pfizer, Novartis, Eli Lilly, Amgen and Tecoland and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alendronate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alendronate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alendronate Market Segment Percentages, by Type, 2021 (%)
5 mg Tablets
10 mg Tablets
35 mg Tablets
70 mg Tablets
Global Alendronate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alendronate Market Segment Percentages, by Application, 2021 (%)
Postmenopausal Osteoporosis
Men with Osteoporosis
Global Alendronate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alendronate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alendronate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alendronate revenues share in global market, 2021 (%)
Key companies Alendronate sales in global market, 2017-2022 (Estimated), (MT)
Key companies Alendronate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva
Mylan
Apotex
Pfizer
Novartis
Eli Lilly
Amgen
Tecoland
Taj Pharmaceuticals